附件4.2

A系列认股权证

认股权证股份:[_______] 发行日期:

本普通股认购权证(“认股权证”)保证,对于所收到的价值,_[___],而在下午5时或之前(纽约时间)[__],(“终止日期”),但此后不得认购根据开曼群岛法律成立的获豁免公司U Power Limited(“本公司”,最多可达[______]普通股(以下可作调整,称为“认股权证股份”)。根据本认股权证,本公司每股普通股(“普通股”)1股普通股(“普通股”)的收购价应等于第2(B)节所界定的行权价格。

定义。大写的 本文中使用的、未另行定义的术语应具有日期为#年的特定证券购买协议(“购买 协议”)中规定的含义[___],由本公司及其签字人签署。

锻炼身体。

行使认股权证。 本认股权证所代表的购买权的全部或部分行使,可于初始行使日期或之后及终止日期当日或之前的任何时间或任何时间,以电子邮件(或电子邮件附件)提交的行使权利通知(“行使权利通知”)正式签署的传真副本或PDF副本交付本公司。在上述行权日期之后(I)两(2)个交易日和(Ii)构成标准结算期的交易天数(见第 节2(D)(I)节)之前的 内,持有人应以电汇或向美国银行开出的本票交付适用行权通知中指定的认股权证股票的总行使价,除非下文第2(C)节规定的无现金行权程序已在适用行权通知中列明。不需要任何墨水原件的行权通知,也不需要任何行权通知的任何担保(或其他类型的担保或公证)。 即使本协议有任何相反规定,在持有人购买了本协议项下所有可用认股权证股份并已全部行使认股权证之前,持有人不应被要求将本认股权证实际交还本公司 ,在此情况下, 持有人应在向本公司交付最终行使通知 之日起三(3)个交易日内将本认股权证交回本公司注销。本认股权证的部分行使导致购买本协议项下可供购买的认股权证股份总数的一部分,其效果是将本协议项下可购买的已发行认股权证股份数量减少至与适用的认股权证股份购买数量相等的数额。持有人和公司应保存记录,显示所购买的认股权证股票数量和购买日期。公司应在收到行使通知之日起1个工作日内提交对行使通知的任何反对意见。持有人及任何受让人接受本认股权证后,确认并同意 由于本段的规定,在购买本认股权证部分股份后,在任何给定时间可供购买的认股权证股份数目可能少于本认股权证票面所载金额。

行权价。 本认股权证项下每股普通股的行权价为美元[___][插入交易采购价格],以本协议下的 调整为准(“行使价”)。行权价格应在交易结束日(“重置日”)后第三十(30)个交易日(“重置日”)后立即重置至等于紧接重置日前二十(20)个交易日普通股在交易市场上的三个最低每股VWAP之和的算术平均值的105%的价格。

无现金行使。 如果在行使本协议的任何时候,没有有效的登记声明登记向持有人发行认股权证股票,或者其中包含的招股说明书无法 用于向持有人发行认股权证股票,则本认股权证也可以在该 时间通过“无现金行使”的方式全部或部分行使,即持有人有权获得相当于通过除以 所得商数的认股权证股份的数量[(A-B)(X)](A)凡:

(A) = 适用的:(I)在紧接适用的行使通知的日期之前的交易日的VWAP,如果该行使通知是(1)在非交易日的交易日(A)和(2)在该交易日“正常交易时间”(根据联邦证券法颁布的NMS法规第600(B)条的定义)开盘前的交易日,(Ii)在持有者的选择下,(Y)适用行使通知日期前一个交易日的VWAP,或(Z)在持有人签立适用行使通知之时主要交易市场上普通股的买入价,如行使通知是在交易日的“正常交易时间”内执行,并根据本条例第2(A)节在其后两(2)小时内(包括至交易日“正常交易时间”结束后两(2)小时内交付)或(Iii))在适用的行使通知的日期是交易日,且该行使通知是在该交易日的“正常交易时间”结束后,根据本协议第2(A)节的规定签立和交付的,则为VWAP;

(B) = 本认股权证的行使价,按以下规定调整;以及

(X) = 根据本认股权证的条款行使本认股权证时可发行的认股权证股份数目,前提是行使该认股权证的方式为现金行使而非无现金行使。

如果认股权证股票是以这种无现金方式发行的,双方确认并同意,根据证券法第3(A)(9)节,认股权证股票应具有正在行使的认股权证的登记特征。公司 同意不采取任何与第2(C)款相抵触的立场。在不限制第2(C)节中规定的无现金行使条款、第2(D)(I)节中的违约金条款或第2(D)(Iv)节中的买入条款的情况下,不存在要求本公司以现金净额结算本认股权证的情况。

“买入价” 指在任何日期由下列条款中的第一项确定的价格,该价格适用于:(A)如果普通股随后在交易市场上市或报价,则为彭博新闻社报道的普通股随后在交易市场上市或报价的当时(或最近的先前日期)交易市场上普通股的买入价(根据交易日上午9:30开始计算)。(纽约时间)至下午4:02(纽约时间)),(B)如果OTCQB或OTCQX不是交易市场,普通股在OTCQB或OTCQX(以适用者为准)该日期(或最近的前一个日期)的成交量加权平均价,(C)如果普通股没有在OTCQB或OTCQX上市或报价,并且如果普通股的价格随后在粉色公开市场(或 继承其报告价格职能的类似组织或机构)报告,则如此报告的普通股的最新投标价格, 或(D)在所有其他情况下,一股普通股的公允市值由一名独立评估师真诚地选择,由当时尚未偿还并为本公司合理接受的多数证券的购买者 选定,费用和支出应由本公司支付。

“VWAP” 指于任何日期由下列第一项适用的价格决定的价格:(A)如普通股当时在交易市场上市或报价,则指彭博资讯(Bloomberg L.P.)自上午9:30起的交易日(根据交易日 起)普通股在该日期(或最近的前一个日期)的每日成交量加权平均价。(纽约市时间)至下午4:02(纽约时间)),(B)如果OTCQB或OTCQX不是交易市场,则为适用的OTCQB或OTCQX在该日期(或最近的前一日期)普通股的加权平均价,(C)如果普通股当时没有在OTCQB或OTCQX上市或报价,并且如果普通股的价格随后在粉色公开市场(或继承其报告价格职能的类似组织或机构)上报告,则如此报告的普通股的最新出价 ,或(D)在所有其他情况下一股普通股的公允市值,由持有该证券多数权益的购买者真诚选择的独立评估师确定,该股票当时尚未发行且合理地被本公司接受,其费用和开支由本公司支付。

2

尽管本协议有任何相反规定 ,在终止日,本认股权证应根据第 2(C)节通过无现金行使方式自动行使。

锻炼的机械学。

行使时交付认股权证 股票。如果公司当时是托管系统(“DWAC”)的参与者,并且 (A)有一份有效的登记声明允许 持有人向 持有人发行或转售认股权证股票,则公司应安排转让代理将根据本协议购买的认股权证股票通过 持有人在托管信托公司的存款或提款的余额账户记入账户,从而将根据本协议购买的认股权证股份转给 持有人,或(B)认股权证是通过无现金行使行使的。或以其他方式将持有人或其指定人的姓名登记在本公司股东名册内,作为持有人根据该行使而有权获得的认股权证股份数目的持有人 行使并将有关该等认股权证股份的证书实物交付至持有人在行使认股权证通知中指定的地址 ,日期为(I)行权通知送交本公司后两(2)个交易日中最早的日期,(br}(Ii)向本公司交付行使权总价后的一(1)个交易日,及(Iii)由向本公司交付行使权通知后的标准结算期组成的交易日的数目(该日期,即“认股权证股份交付日期”);在交付行使通知后,就SHO规则而言,持有人应被视为已行使本认股权证的认股权证股份的记录持有人,而不论认股权证股份的交付日期 ,但前提是在(I)两(2)个交易日及(Ii)组成标准结算期的交易日内收到行使总价(无现金行使除外)的付款 ,以较早者为准。如公司因任何原因未能向持有人交付认股权证股份,但须于认股权证股份交割日期发出行使通知,则公司应就行使认股权证股份每1,000美元向持有人支付现金,作为违约金,而非罚款(以适用行使认股权证通知日期普通股的VWAP为基准)。于该认股权证股份交割日后的每个交易日每交易日10美元(在该等算定损害赔偿开始产生后的第三个交易日增加至每个交易日20美元),直至该认股权证股份交付或持有人 撤销该等行使为止。公司同意保留一名参与FAST计划的转让代理,只要本认股权证 仍未履行并可行使。本文所用的“标准结算期”指在行使通知交付之日在本公司一级交易市场上与普通股有关的标准结算期 ,以若干交易日为单位。

行使时交付新的 认股权证。如本认股权证已部分行使,本公司应应持有人的要求及在认股权证股份交付时交回本认股权证证书,向持有人交付一份新的认股权证,证明持有人有权购买本认股权证所要求的未购买认股权证股份,而新认股权证在所有其他方面应与本认股权证完全相同。

撤销权。 如果本公司未能促使转让代理在认股权证股份交割日之前根据第2(D)(I)条将认股权证股份转让给持有人 ,则持有人将有权撤销该项行使。

3

未能在行使时及时交付认股权证股票的买入补偿 。除持有人可享有的任何其他权利外,如果本公司未能促使转让代理根据上文第(Br)2(D)(I)节的规定在认股权证股份交割日或之前行使认股权证股份,并且在该日期之后,持有人被其 经纪人要求购买(在公开市场交易或其他情况下)或持有人的经纪公司以其他方式购买,为满足持有人出售认股权证股份而交付的普通股 ,公司应(A)以现金形式向持有人支付(如有)(X)持有人的总收购价(包括经纪佣金、如此购买的普通股)超过(Y)的金额乘以(1)本公司须在 发行时间向持有人交付的与行权有关的认股权证股份数目,(2)执行导致该购买义务的卖单的价格,以及(B)在持有人的选择下, 恢复认股权证未获履行的部分及同等数目的认股权证股份(在此情况下,该项行使应被视为撤销),或向持有人交付假若 公司及时履行其行使及交付义务将会发行的普通股数目。例如,如果持有人购买总购买价为11,000美元的普通股,以支付与试图行使普通股有关的买入,而总销售价 导致该购买义务为10,000美元,则根据上一句(A)款,本公司应向持有人支付1,000美元。持有人应向公司提供书面通知,说明就买入而应向持有人支付的金额,并应公司的要求提供此类损失金额的证据。本协议并不限制持有人根据本协议在法律或衡平法上可寻求任何其他补救措施的权利,包括但不限于特定履行判令及/或有关本公司未能按本协议条款所要求在行使认股权证时及时交付普通股的强制令豁免。

没有分数 股票或Scrip。本认股权证行使时,不得发行代表零碎股份的零碎股份或代表零碎股份的股票。如 股份持有人于行使该权力时有权购买任何零碎股份,本公司将于其选择时就该最后零碎股份支付现金调整,金额为该零碎股份乘以行使价,或 向上舍入至下一个完整股份。

手续费、税金和费用。发行认股权证股票应免费向持有人收取与发行该等认股权证股份有关的任何发行或转让税或其他附带费用,所有税项及开支均由本公司支付,而该等认股权证股份应以持有人的名义或按持有人指示的名称发行;然而, 如认股权证股份以持有人以外的名义发行,则本认股权证于交回行使时,须附同由持有人正式签署的转让表格,而本公司可要求支付一笔足以偿还其附带的任何转让税的款项,作为条件。本公司应支付当日处理任何行使通知所需的所有转让代理费用,以及当日以电子方式交付认股权证股份所需的所有费用予存托信托公司(或履行类似职能的另一间已成立结算公司)。

账簿关闭。 根据本协议的条款,公司不会以任何妨碍及时行使本认股权证的方式关闭其股东账簿或记录。

4

霍尔德的 锻炼限制。本公司不得行使本认股权证,持有人亦无权根据第2条或其他规定行使本认股权证的任何部分,惟在适用行使通知所载于行使后的发行生效后,持有人(连同持有人的联营公司,以及与持有人或持有人的任何联属公司作为一个集团行事的任何其他人士(该等人士,“出让方”))将 实益拥有超出实益拥有权限额(定义见下文)的权利。就前述句子而言,持有人及其联营公司及出资方实益拥有的普通股股数应包括因行使本认股权证而可发行的普通股数量,但不包括因(I)行使持股权证或其任何关联公司或出让方实益拥有的剩余未行使部分及(Ii)行使或转换本公司任何其他证券(包括但不限于,任何其他普通股等价物),但须受有关转换或行使限制的限制 ,类似于本协议所载由持有人或其任何联营公司或授权方实益拥有的限制 。除上一句所述外,就本第2(E)条而言,实益所有权应根据《交易所法案》第13(D)节及据此颁布的规则和条例计算, 持有人确认本公司并未向持有人表示该计算符合《交易所法案》第13(D)条的规定 ,并由持有人独自负责根据该条款提交的任何时间表。在第2(E)款中包含的限制适用的范围内,确定本认股权证是否可行使(与持有人与任何关联方和出资方共同拥有的其他证券有关)以及本认股权证的哪一部分可行使,应由持有人自行决定,提交行使通知应视为持有人决定是否可行使本认股权证(与持有人与任何关联方和出资方共同拥有的其他证券有关) 以及本认股权证的哪部分可行使。在每种情况下,本公司均受实益所有权限制,且本公司无义务核实或确认该等决定的准确性。此外,上述关于任何集团地位的决定应根据《交易所法案》第13(D)节及其颁布的规则和条例来确定。就本第2(E)条而言,在厘定已发行普通股数目时,持有人可依据(A)本公司向监察委员会提交的最新定期或年度报告(视属何情况而定)、(B)本公司较新的公告或(C)本公司或转让代理较新发出的书面通知所反映的已发行普通股数量。如持有人提出书面或口头要求,本公司须于一(1) 个交易日内以口头及书面方式向持有人确认当时已发行的普通股数目。在任何情况下,普通股已发行股份的数目 应由持有人或其联营公司或归属方自报告该等已发行普通股数目 之日起,于转换或行使本公司证券(包括本认股权证)后厘定。“实益拥有权限额”应为在行使本认股权证可发行普通股生效后立即发行的普通股数量的4.99% 。持有人在通知本公司后,可增加或减少本第2(E)节的实益所有权限制条文,但实益拥有权限制 在任何情况下不得超过紧随持有人行使本认股权证而发行普通股后已发行普通股数目的9.99%,而本第2(E)节的规定将继续适用。 受益所有权限制的任何增加都不会生效,直到ST 本段规定的解释和实施方式不应严格遵守第2(E)节的条款,以纠正本段(或其任何部分)可能存在缺陷或与本文所载的预期受益所有权限制不一致的情况,或作出必要或可取的更改或补充以适当地实施此类限制。 本段包含的限制应适用于本认股权证的后续持有人。

5

做了一些调整。

分红 和拆分。如果本公司在本认股权证尚未发行期间的任何时间:(I)派发股息或以其他方式对其普通股或任何其他股本或股本等值证券进行分派(为免生疑问,不包括本公司在行使本认股权证时发行的任何普通股),(Ii)将其已发行的 普通股细分为更多数量的股份,(Iii)将其已发行普通股 合并(包括以反向分拆的方式)为较少数目的股份或(Iv)透过将其普通股重新分类而发行本公司的任何股本,则在每一种情况下,行使价须乘以一个分数,分子为紧接该事件发生前已发行的普通股(不包括库存股,如有的话)的股份数目,而分母为紧接该事件发生后已发行的普通股数目。在行使本认股权证时可发行的股份数目应按比例调整 ,以使本认股权证的总行使价格保持不变。根据本第3(A)条作出的任何调整应在确定有权收取该等股息或分派的股东的登记日期后 立即生效 ,如属分拆、合并或重新分类,则应于生效日期后立即生效。

管辖权。 有关本保证书的解释、有效性、执行和解释的所有问题均应根据《购买协议》的规定作出决定。

限制。 持有人承认,在行使本认股权证时获得的认股权证股票,如果未登记且持有人未使用无现金行使,则在转售时将受到州和联邦证券法的限制。

非豁免和 费用。持有人的任何交易过程或任何延误或未能行使本协议项下的任何权利,均不得视为放弃该等权利或以其他方式损害持有人的权利、权力或补救。在不限制本认股权证或购买协议的任何其他条款的情况下,如果本公司故意及明知不遵守本认股权证的任何条款,导致持有人遭受任何重大损害,本公司应向持有人支付足以支付持有人因收取根据本协议或以其他方式执行本协议项下的任何权利、权力或补救措施而产生的 任何款项而产生的任何费用和开支,包括但不限于合理的律师费,包括上诉诉讼费用。

6

通知。 本公司要求或允许向持有人发出或交付的任何通知、请求或其他文件应按照购买协议的通知条款 交付。

7

责任限制 。如持有人并无采取任何肯定行动以行使本认股权证以购买认股权证 股份,亦无列举持有人的权利或特权,则本协议任何条文均不会导致持有人就购买任何普通股的价格或作为本公司股东而承担任何责任,不论该等责任是由本公司或本公司的债权人主张的。

补救措施。 持有人除了有权行使法律授予的所有权利,包括追讨损害赔偿外,还有权具体 履行其在本认股权证项下的权利。本公司同意,金钱赔偿不足以补偿因其违反本认股权证规定而蒙受的任何损失,因此,本公司同意放弃且不在任何针对具体履约的诉讼中提出法律补救即已足够的抗辩理由。

继任者和 分配。在适用证券法的规限下,本认股权证及本认股权证所证明的权利及义务,对本公司的继承人及获准受让人及持有人的继承人及获准受让人的利益具有约束力。本认股权证的 条款旨在使本认股权证的任何持有人不时受益,并可由认股权证持有人或认股权证股份持有人执行。

经本公司及持有人书面同意,本认股权证可予修改或修订,或放弃本认股权证的规定。

8

可分割性。 在可能的情况下,本保证书的每一条款均应解释为在适用法律下有效和有效,但如果本保证书的任何条款被适用法律禁止或无效,则该条款在该禁止或无效的范围内无效,但不会使该等条款的其余部分或本保证书的其余条款无效。

Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary and subject to Sections 2(a) and 2(d)(ii), the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

9

Miscellaneous.

No Rights as Shareholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).

Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.

Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

Authorized Shares.

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of completing the issuance of the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Ordinary Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its amended and restated memorandum and articles of association or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

10

Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

Non-waiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or a holder of Warrant Shares.

Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)